These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 25576921)

  • 101. Tumorigenesis and prognostic role of hepatoma-derived growth factor in human gliomas.
    Hsu SS; Chen CH; Liu GS; Tai MH; Wang JS; Wu JC; Kung ML; Chan EC; Liu LF
    J Neurooncol; 2012 Mar; 107(1):101-9. PubMed ID: 22037800
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Combination gene therapy with PTEN and EGFR siRNA suppresses U251 malignant glioma cell growth in vitro and in vivo.
    Han L; Zhang AL; Xu P; Yue X; Yang Y; Wang GX; Jia ZF; Pu PY; Kang CS
    Med Oncol; 2010 Sep; 27(3):843-52. PubMed ID: 19728186
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Knockdown of ribosomal protein S15A induces human glioblastoma cell apoptosis.
    Zhang C; Fu J; Xue F; Ryu B; Zhang T; Zhang S; Sun J; Xu X; Shen Z; Zheng L; Chen X
    World J Surg Oncol; 2016 Apr; 14():129. PubMed ID: 27130037
    [TBL] [Abstract][Full Text] [Related]  

  • 104. MRP3: a molecular target for human glioblastoma multiforme immunotherapy.
    Kuan CT; Wakiya K; Herndon JE; Lipp ES; Pegram CN; Riggins GJ; Rasheed A; Szafranski SE; McLendon RE; Wikstrand CJ; Bigner DD
    BMC Cancer; 2010 Sep; 10():468. PubMed ID: 20809959
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Combination therapy with Gamma Knife radiosurgery and antisense EGFR for malignant glioma in vitro and orthotopic xenografts.
    Li Y; Jia Q; Zhang J; Han L; Xu D; Zhang A; Zhang Y; Zhang Z; Pu P; Kang C
    Oncol Rep; 2010 Jun; 23(6):1585-91. PubMed ID: 20428813
    [TBL] [Abstract][Full Text] [Related]  

  • 106. RBM17 controls apoptosis and proliferation to promote Glioma progression.
    Lu J; Li Q; Cai L; Zhu Z; Guan J; Wang C; Xia J; Xia L; Wen M; Zheng W; Su Z; Wang C
    Biochem Biophys Res Commun; 2018 Oct; 505(1):20-28. PubMed ID: 30227940
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Novel PARP1/2 inhibitor mefuparib hydrochloride elicits potent in vitro and in vivo anticancer activity, characteristic of high tissue distribution.
    He JX; Wang M; Huan XJ; Chen CH; Song SS; Wang YQ; Liao XM; Tan C; He Q; Tong LJ; Wang YT; Li XH; Su Y; Shen YY; Sun YM; Yang XY; Chen Y; Gao ZW; Chen XY; Xiong B; Lu XL; Ding J; Yang CH; Miao ZH
    Oncotarget; 2017 Jan; 8(3):4156-4168. PubMed ID: 27926532
    [TBL] [Abstract][Full Text] [Related]  

  • 108. The melatonin-MT1 receptor axis modulates tumor growth in PTEN-mutated gliomas.
    Ma H; Wang Z; Hu L; Zhang S; Zhao C; Yang H; Wang H; Fang Z; Wu L; Chen X
    Biochem Biophys Res Commun; 2018 Feb; 496(4):1322-1330. PubMed ID: 29408377
    [TBL] [Abstract][Full Text] [Related]  

  • 109. RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivo.
    Hendruschk S; Wiedemuth R; Aigner A; Töpfer K; Cartellieri M; Martin D; Kirsch M; Ikonomidou C; Schackert G; Temme A
    Neuro Oncol; 2011 Oct; 13(10):1074-89. PubMed ID: 21788344
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Inhibition of BAD-Ser99 phosphorylation synergizes with PARP inhibition to ablate PTEN-deficient endometrial carcinoma.
    Zhang X; Huang P; Wang L; Chen S; Basappa B; Zhu T; Lobie PE; Pandey V
    Cell Death Dis; 2022 Jun; 13(6):558. PubMed ID: 35725817
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Targeted Brain Tumor Radiotherapy Using an Auger Emitter.
    Pirovano G; Jannetti SA; Carter LM; Sadique A; Kossatz S; Guru N; Demétrio De Souza França P; Maeda M; Zeglis BM; Lewis JS; Humm JL; Reiner T
    Clin Cancer Res; 2020 Jun; 26(12):2871-2881. PubMed ID: 32066626
    [TBL] [Abstract][Full Text] [Related]  

  • 112. L-type amino-acid transporter 1 (LAT1): a therapeutic target supporting growth and survival of T-cell lymphoblastic lymphoma/T-cell acute lymphoblastic leukemia.
    Rosilio C; Nebout M; Imbert V; Griessinger E; Neffati Z; Benadiba J; Hagenbeek T; Spits H; Reverso J; Ambrosetti D; Michiels JF; Bailly-Maitre B; Endou H; Wempe MF; Peyron JF
    Leukemia; 2015 Jun; 29(6):1253-66. PubMed ID: 25482130
    [TBL] [Abstract][Full Text] [Related]  

  • 113. RAD51 can inhibit PDGF-B-induced gliomagenesis and genomic instability.
    Westermark UK; Lindberg N; Roswall P; Bråsäter D; Helgadottir HR; Hede SM; Zetterberg A; Jasin M; Nistér M; Uhrbom L
    Neuro Oncol; 2011 Dec; 13(12):1277-87. PubMed ID: 21926087
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Nitric oxide released from JS-K induces cell death by mitotic catastrophe as part of necrosis in glioblastoma multiforme.
    Günzle J; Osterberg N; Saavedra JE; Weyerbrock A
    Cell Death Dis; 2016 Sep; 7(9):e2349. PubMed ID: 27584787
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Transglutaminase 2 Inhibition Reverses Mesenchymal Transdifferentiation of Glioma Stem Cells by Regulating C/EBPβ Signaling.
    Yin J; Oh YT; Kim JY; Kim SS; Choi E; Kim TH; Hong JH; Chang N; Cho HJ; Sa JK; Kim JC; Kwon HJ; Park S; Lin W; Nakano I; Gwak HS; Yoo H; Lee SH; Lee J; Kim JH; Kim SY; Nam DH; Park MJ; Park JB
    Cancer Res; 2017 Sep; 77(18):4973-4984. PubMed ID: 28754668
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Driver or passenger effects of augmented c-Myc and Cdc20 in gliomagenesis.
    Ji P; Zhou X; Liu Q; Fuller GN; Phillips LM; Zhang W
    Oncotarget; 2016 Apr; 7(17):23521-9. PubMed ID: 26993778
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Contextual synthetic lethality of cancer cell kill based on the tumor microenvironment.
    Chan N; Pires IM; Bencokova Z; Coackley C; Luoto KR; Bhogal N; Lakshman M; Gottipati P; Oliver FJ; Helleday T; Hammond EM; Bristow RG
    Cancer Res; 2010 Oct; 70(20):8045-54. PubMed ID: 20924112
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Tumour cell retention of rucaparib, sustained PARP inhibition and efficacy of weekly as well as daily schedules.
    Murray J; Thomas H; Berry P; Kyle S; Patterson M; Jones C; Los G; Hostomsky Z; Plummer ER; Boddy AV; Curtin NJ
    Br J Cancer; 2014 Apr; 110(8):1977-84. PubMed ID: 24556618
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Hepatitis B virus-associated hepatocellular carcinoma with Smc5/6 complex deficiency is susceptible to PARP inhibitors.
    Funato K; Otsuka M; Sekiba K; Miyakawa Y; Seimiya T; Shibata C; Kishikawa T; Fujishiro M
    Biochem Biophys Res Commun; 2022 Jun; 607():89-95. PubMed ID: 35367833
    [TBL] [Abstract][Full Text] [Related]  

  • 120. New perspective on DNA response pathway (DDR) in glioblastoma, focus on classic biomarkers and emerging roles of ncRNAs.
    Pirlog BO; Ilut S; Pirlog R; Chiroi P; Nutu A; Radutiu DI; Cuc GD; Berindan-Neagoe I; Nabavi SF; Filosa R; Nabavi SM
    Expert Rev Mol Med; 2023 May; 25():e18. PubMed ID: 37154101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.